136 related articles for article (PubMed ID: 18281929)
1. Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.
Papanastasiou I; Tsotinis A; Kolocouris N; Prathalingam SR; Kelly JM
J Med Chem; 2008 Mar; 51(5):1496-500. PubMed ID: 18281929
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.
Kelly JM; Quack G; Miles MM
Antimicrob Agents Chemother; 2001 May; 45(5):1360-6. PubMed ID: 11302796
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
Zoidis G; Tsotinis A; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Org Biomol Chem; 2008 Sep; 6(17):3177-85. PubMed ID: 18698478
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of diphenoxyadamantane alkylamines with pharmacological interest.
Georgiadis MO; Kourbeli V; Ioannidou V; Karakitsios E; Papanastasiou I; Tsotinis A; Komiotis D; Vocat A; Cole ST; Taylor MC; Kelly JM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1278-1281. PubMed ID: 30981579
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones.
Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM
ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of Nifurtimox-Adamantane Adducts with Trypanocidal Activity.
Foscolos AS; Papanastasiou I; Tsotinis A; Taylor MC; Kelly JM
ChemMedChem; 2019 Jul; 14(13):1227-1231. PubMed ID: 31066972
[TBL] [Abstract][Full Text] [Related]
7. Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR Study.
Pardali V; Giannakopoulou E; Balourdas DI; Myrianthopoulos V; Taylor MC; Šekutor M; Mlinarić-Majerski K; Kelly JM; Zoidis G
Curr Pharm Des; 2020; 26(8):838-866. PubMed ID: 32039675
[TBL] [Abstract][Full Text] [Related]
8. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
[TBL] [Abstract][Full Text] [Related]
9. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
Zoidis G; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Eur J Med Chem; 2010 Nov; 45(11):5022-30. PubMed ID: 20805012
[TBL] [Abstract][Full Text] [Related]
11. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
[TBL] [Abstract][Full Text] [Related]
12. The anti-influenza virus drug rimantadine has trypanocidal activity.
Kelly JM; Miles MA; Skinner AC
Antimicrob Agents Chemother; 1999 Apr; 43(4):985-7. PubMed ID: 10103219
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of bioactive adamantane spiro heterocycles.
Kolocouris N; Zoidis G; Foscolos GB; Fytas G; Prathalingham SR; Kelly JM; Naesens L; De Clercq E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4358-62. PubMed ID: 17588747
[TBL] [Abstract][Full Text] [Related]
14. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
15. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
[TBL] [Abstract][Full Text] [Related]
16. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
Vodnala SK; Lundbäck T; Yeheskieli E; Sjöberg B; Gustavsson AL; Svensson R; Olivera GC; Eze AA; de Koning HP; Hammarström LG; Rottenberg ME
J Med Chem; 2013 Dec; 56(24):9861-73. PubMed ID: 24283924
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
[TBL] [Abstract][Full Text] [Related]
19. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
[TBL] [Abstract][Full Text] [Related]
20. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
